The agreement of merger and acquisition imminent between the group with stars and stripes Pfizer and Astra Zeneca UK group has collected a large volume of transactions in the square, given the importance, in terms of commitment of capital operation.
We see, in fact, they have positioned themselves as the two titles, in beautiful full euphoria of investments for the tantalizing challenge of the pharmaceutical industry.
The agreement Pfizer-Astra Zeneca
Began to fare well in yesterday’s session titled Pfizer with a quotation amounted to 30.86, an increase of 2.02%. Provided further rises in prices, even up to a target of € 34,15.
But Wall Street is not the only one to be in turmoil. Not even on the few scommetsse title Astra Zeneca, British group, which is experiencing a surge even higher as much as 6 percentage points.
On the other hand, the fact that one of the two groups, both American (Pfizer), while the other is British (Astra Zeneca) is a not insignificant detail, given the evolution of the cable Usd Dollar / Sterling. The pound reached its highest historical appreciation against the dollar. Is increasing the impressiveness of which is equal to $ 101 billion, which translated into sterling, equivalent to 60 billion.
Such rumors, therefore, is making the rounds of the international markets and not only has its headquarters on Wall Street.
It seems, however, according to very recent rumors that the agreement is not so obvious as it was believed at the beginning. Both groups are well positioned on the market. This is not, apparently, a merger of convenience. Suffice it to observe their market valuations for both well in excess of $ 50 billion. Pfizer is evaluated more than twice, and only in theory would have more items chapter, since it seems to have come first refusal on the part of Astra Zeneca.
Surely, to affect any assessment, placement in the U.S. Pfizer, whose performance is fluctuating stock market on Wall Street, a little affected ‘by the recent uncertainty in the U.S. economy, the weak dollar, fear of new foreign competitors . And so, the title alternates between positive trends and negative trends.
We can understand, then, how the system may be part of a strategic choice that may conceal some fears.